Breaking News, Promotions & Moves

Cryoport Appoints Robert Hariri to its Board

Cellular therapy pioneer is most recognized for his discovery of pluripotent stem cells

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cryoport, Inc., a provider of cryogenic logistics services to the life sciences industry, has appointed Robert Hariri, MD, Ph.D. to its board of directors.   Dr. Hariri is the chairman, founder and chief scientific officer of Celgene Cellular Therapeutics, a human cellular therapeutics company and wholly owned subsidiary of Celgene Corp. He has pioneered the use of stem cells and biomaterials to treat a range of diseases and has made transformative contributions in the field of tissue engineer...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters